News Quantified

JAGX – jaguar health, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split

Jaguar Health Announces Acceptance of two Late-Breaking Abstracts for Liquid Oral Crofelemer Treatment of Intestinal Failure in Pediatric Patients at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition (ESPGHAN)

Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs [Yahoo! Finance]

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression [Yahoo! Finance]

Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts [Yahoo! Finance]

Form 8-K Jaguar Health, Inc. For: Apr 24

Form PRE 14A Jaguar Health, Inc. For: May 22

Form 8-K Jaguar Health, Inc. For: Apr 20

Form 8-K Jaguar Health, Inc. For: Apr 07

Form S-8 Jaguar Health, Inc.

Top News Gainers

6/11 Jaguar Health Subsidiary Receiving Preclinical Services Funded by the National Institute of Allergy and Infectious Diseases in Support of Development of Lechlemer Drug Product Candidate for Cholera Indication 35.0%

10/30 Jaguar Health Subsidiary Napo Pharmaceuticals Enters ex-U.S. Distribution Agreement for Mytesi (Crofelemer) with TannerGAP, Inc. 28.6%

11/12 Jaguar Health to Host Investor Call Nov. 14th at 9 a.m. Eastern Regarding Interim Analysis of HALT-D Study of Mytesi (Crofelemer) for Prevention of Diarrhea in Breast Cancer Patients, Q3 Financials & Business Updates 25.7%

12/31 Jaguar Health Inc (NASDAQ: JAGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 17.8%

9/30 Jaguar Health Subsidiary Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Application 12.0%

9/12 Jaguar Health Inc (NASDAQ: JAGX) is now covered by analysts at LADENBURG THALM/SH SH. They set a "buy" rating on the stock. 10.8%

8/20 Form 3 Jaguar Health, Inc. For: Aug 13 Filed by: Lizak Carol R. 10.3%

6/24 Jaguar Health Regains Compliance with All Applicable Nasdaq Stock Market Listing Standards 9.5%

9/16 Jaguar Health's Mytesi Drug Product Now Approved for Sale in Puerto Rico 8.3%

12/26 Form 8-K Jaguar Health, Inc. For: Dec 20 6.9%

Top News Decliners

11/14 Jaguar Health Inc (NASDAQ: JAGX) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -28.8%

4/16 Form 8-K Jaguar Health, Inc. For: Apr 15 -22.1%

8/14 Form 10-Q Jaguar Health, Inc. For: Jun 30 -20.9%

6/6 Jaguar Health, Inc. Announces 1-for-70 Reverse Stock Split -19.0%

3/23 Form 8-K Jaguar Health, Inc. For: Mar 21 -19.0%

7/5 Form FWP Jaguar Health, Inc. Filed by: Jaguar Health, Inc. -15.1%

9/24 Form 8-K Jaguar Health, Inc. For: Sep 24 -12.9%

5/11 Jaguar Health readies $10M equity offering [Seeking Alpha] -12.6%

7/15 Form S-1/A Jaguar Health, Inc. -12.4%

10/1 Jaguar Health Files Final Canalevia (Crofelemer) Technical Section for Proposed Indication of Chemotherapy-Induced Diarrhea in Dogs -12.2%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day